GlaxoSmithKline CR`s Working Capital reached 1,154 CZK mil in 2017. This is 10.1 % more than in the previous year.
Buy Working Capital data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | 92.4 | 111 | 48.4 | 124 | 67.4 | ||||||||
| Bayer Czech Republic | CZK mil | ... | ... | ... | 199 | 315 | 353 | 356 | 463 | ||||||||||
| GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | 1,697 | 1,744 | 1,837 | 1,184 | 983 | ||||||||||
| Merck Czech Republic | CZK mil | ... | ... | 389 | 449 | 491 | 430 | 434 | |||||||||||
| Novartis Czech Republic | CZK mil | 604 | 517 | 1,375 | 886 | 951 | |||||||||||||
| Pfizer Czech Republic | CZK mil | ... | ... | 1,530 | 552 | 1,028 | 523 | 1,107 | |||||||||||
| Roche Czech Republic | CZK mil | ... | ... | ... | 694 | 1,007 | 1,321 | 1,532 | 1,659 | ... | |||||||||
| Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | 1,826 | 1,888 | 1,588 | 1,177 | 1,420 | |||||||||
| Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 46.3 | 32.7 | 56.7 | 77.3 | ||
| Walmark | CZK mil | ... | ... | ... | 621 | 500 | 406 | 401 | 212 |
Helgi Library 
